233 related articles for article (PubMed ID: 29332144)
1. Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
Jacobson GA; Raidal S; Hostrup M; Calzetta L; Wood-Baker R; Farber MO; Page CP; Walters EH
Drug Saf; 2018 May; 41(5):441-449. PubMed ID: 29332144
[TBL] [Abstract][Full Text] [Related]
2. Benefit-risk assessment of long-acting beta2-agonists in asthma.
Jackson CM; Lipworth B
Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
[TBL] [Abstract][Full Text] [Related]
3. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
Cossette B; Beauchesne MF; Forget A; Lemière C; Larivée P; Rey E; Blais L
Ann Allergy Asthma Immunol; 2014 May; 112(5):459-64. PubMed ID: 24656659
[TBL] [Abstract][Full Text] [Related]
4. Beta2-agonist eutomers: a rational option for the treatment of asthma?
Boulton DW; Fawcett JP
Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
[TBL] [Abstract][Full Text] [Related]
5. Safety of β2-Agonists in Asthma: Linking Mechanisms, Meta-Analyses and Regulatory Practice.
Dissanayake SB
AAPS J; 2015 May; 17(3):754-7. PubMed ID: 25712726
[TBL] [Abstract][Full Text] [Related]
6. LABAs in asthmatic children: highlights and new inside.
Miraglia del Giudice M; Matera MG; Capristo C; Conte M; Santaniello F; Chinellato I; Leonardi S; Miraglia del Giudice MC; Perrone L
Pulm Pharmacol Ther; 2013 Oct; 26(5):540-3. PubMed ID: 23583567
[TBL] [Abstract][Full Text] [Related]
7. Controversies regarding long-acting β2-agonists.
Khianey R; Oppenheimer J
Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):345-54. PubMed ID: 21659855
[TBL] [Abstract][Full Text] [Related]
8. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
9. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of asthma medication use related to US Food and Drug Administration long-acting β2-agonist regulation from 2005-2011.
Butler MG; Zhou EH; Zhang F; Wu YT; Wu AC; Levenson MS; Wu P; Seymour S; Toh S; Iyer A; Iyasu S; Baker MA
J Allergy Clin Immunol; 2016 Mar; 137(3):710-7. PubMed ID: 26725997
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
Tamm M; Richards DH; Beghé B; Fabbri L
Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
[TBL] [Abstract][Full Text] [Related]
12. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
Rabe KF
Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
[TBL] [Abstract][Full Text] [Related]
13. [Safety of beta-agonists in asthma].
Oscanoa TJ
Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(1):43-53. PubMed ID: 25036448
[TBL] [Abstract][Full Text] [Related]
14. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
[TBL] [Abstract][Full Text] [Related]
15. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
[TBL] [Abstract][Full Text] [Related]
16. Long-acting beta-agonists and the risk of intensive care unit admission in children.
Jacobs TS; Jones BL; MacGinnitie AJ
J Asthma; 2012 Jun; 49(5):450-5. PubMed ID: 22540879
[TBL] [Abstract][Full Text] [Related]
17. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
18. Long-Acting Beta Agonists Enhance Allergic Airway Disease.
Knight JM; Mak G; Shaw J; Porter P; McDermott C; Roberts L; You R; Yuan X; Millien VO; Qian Y; Song LZ; Frazier V; Kim C; Kim JJ; Bond RA; Milner JD; Zhang Y; Mandal PK; Luong A; Kheradmand F; McMurray JS; Corry DB
PLoS One; 2015; 10(11):e0142212. PubMed ID: 26605551
[TBL] [Abstract][Full Text] [Related]
19. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
Patel M; Thomson NC
Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
[TBL] [Abstract][Full Text] [Related]
20. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
